Patents by Inventor Dennis R. Sindrey

Dennis R. Sindrey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Connective tissue stimulating peptides
    Patent number: 11384117
    Abstract: Novel peptides are described which comprise an amino acid motif selected from the group consisting of “PG”, “GP”, “PI” and “IG” and having up to 10 amino acids upstream and/or downstream of the amino acid motif, wherein “P” in the motif is proline or hydroxyproline and the peptide stimulates the development, maintenance and repair of bone, cartilage and associated connective tissue. The invention further relates to pharmaceutical compositions of these peptides, as well as therapeutic and prophylactic uses of such peptides.
    Type: Grant
    Filed: March 28, 2018
    Date of Patent: July 12, 2022
    Assignee: Octane Orthobiologics Inc.
    Inventors: Dennis R. Sindrey, Sydney M. Pugh, Timothy J. N. Smith
  • CONNECTIVE TISSUE STIMULATING PEPTIDES
    Publication number: 20190077831
    Abstract: Novel peptides are described which comprise an amino acid motif selected from the group consisting of “PG”, “GP”, “PI” and “IG” and having up to 10 amino acids upstream and/or downstream of the amino acid motif, wherein “P” in the motif is proline or hydroxyproline and the peptide stimulates the development, maintenance and repair of bone, cartilage and associated connective tissue.The invention further relates to pharmaceutical compositions of these peptides, as well as therapeutic and prophylactic uses of such peptides.
    Type: Application
    Filed: March 28, 2018
    Publication date: March 14, 2019
    Inventors: Dennis R. Sindrey, Sydney M. Pugh, Timothy J.N. Smith
  • Connective tissue stimulating peptides
    Patent number: 10202419
    Abstract: Novel peptides are described which comprise an amino acid motif selected from the group consisting of “PG”, “GP”, “PI” and “IG” and having up to 10 amino acids upstream and/or downstream of the amino acid motif, wherein “P” in the motif is proline or hydroxyproline and the peptide stimulates the development, maintenance and repair of bone, cartilage and associated connective tissue. The invention further relates to pharmaceutical compositions of these peptides, as well as therapeutic and prophylactic uses of such peptides.
    Type: Grant
    Filed: September 15, 2015
    Date of Patent: February 12, 2019
    Assignee: Octane Orthobiologics Inc.
    Inventors: Dennis R. Sindrey, Sydney M. Pugh, Timothy J. N. Smith
  • CONNECTIVE TISSUE STIMULATING PEPTIDES
    Publication number: 20160237117
    Abstract: Novel peptides are described which comprise an amino acid motif selected from the group consisting of “PG”, “GP”, “PI” and “IG” and having up to 10 amino acids upstream and/or downstream of the amino acid motif, wherein “P” in the motif is proline or hydroxyproline and the peptide stimulates the development, maintenance and repair of bone, cartilage and associated connective tissue. The invention further relates to pharmaceutical compositions of these peptides, as well as therapeutic and prophylactic uses of such peptides.
    Type: Application
    Filed: September 15, 2015
    Publication date: August 18, 2016
    Inventors: Dennis R. Sindrey, Sydney M. Pugh, Timothy J.N. Smith
  • Connective tissue stimulating peptides
    Patent number: 9133236
    Abstract: Novel peptides are described which comprise an amino acid motif selected from the group consisting of “PG”, “GP”, “PI” and “IG” and having up to 10 amino acids upstream and/or downstream of the amino acid motif, wherein “P” in the motif is proline or hydroxyproline and the peptide stimulates the development, maintenance and repair of bone, cartilage and associated connective tissue. The invention further relates to pharmaceutical compositions of these peptides, as well as therapeutic and prophylactic uses of such peptides.
    Type: Grant
    Filed: February 17, 2009
    Date of Patent: September 15, 2015
    Inventors: Dennis R. Sindrey, Sydney M. Pugh, Timothy J. N. Smith
  • Connective tissue stimulating peptides
    Publication number: 20120156276
    Abstract: Novel peptides are described which comprise an amino acid motif selected from the group consisting of “PG”, “GP”, “PI” and “IG” and having up to 10 amino acids upstream and/or downstream of the amino acid motif, wherein “P” in the motif is proline or hydroxyproline and the peptide stimulates the development, maintenance and repair of bone, cartilage and associated connective tissue. The invention further relates to pharmaceutical compositions of these peptides, as well as therapeutic and prophylactic uses of such peptides.
    Type: Application
    Filed: February 17, 2009
    Publication date: June 21, 2012
    Inventors: Dennis R. Sindrey, Sydney M. Pugh, Timothy J.N. Smith
  • Connective tissue stimulating peptides
    Patent number: 7491691
    Abstract: Novel peptides are described which comprise an amino acid motif selected from the group consisting of “PG”, “GP”, “PI” and “IG” and having up to 10 amino acids upstream and/or downstream of the amino acid motif, wherein “P” in the motif is proline or hydroxyproline and the peptide stimulates the development, maintenance and repair of bone, cartilage and associated connective tissue. The invention further relates to pharmaceutical compositions of these peptides, as well as therapeutic and prophylactic uses of such peptides.
    Type: Grant
    Filed: May 2, 2003
    Date of Patent: February 17, 2009
    Inventors: Dennis R. Sindrey, Sydney M. Pugh, Timothy J. N. Smith
  • Method of purifying human epidermal growth factor
    Patent number: 5290920
    Abstract: Human epidermal growth factor is provided in an ultrapure form characterized by the absence of protein contaminants detectable by capillary electrophoresis analysis. A method for obtaining such ultrapure human epidermal growth factor includes fractionation of a human epidermal growth factor preparation by reversed phase high performance liquid chromatography in the presence of a cationic ion-pairing agent.
    Type: Grant
    Filed: April 16, 1992
    Date of Patent: March 1, 1994
    Assignee: Allelix Biopharmaceuticals Inc.
    Inventors: Dennis R. Sindrey, Chandra M. Dwivedi
  • Essentially pure human parathyroid hormone
    Patent number: 5208041
    Abstract: Human parathyroid hormone is provided in an ultrapure form characterized by the absence of protein contaminants detectable by capillary electrophoresis analysis. A method for obtaining such ultrapure human parathyroid hormone is also described.
    Type: Grant
    Filed: May 23, 1991
    Date of Patent: May 4, 1993
    Assignees: Allelix Biopharmaceuticals Inc., Glaxo Canada Inc.
    Inventor: Dennis R. Sindrey